Health
Novel T-cell therapy shows promise to treat COVID-19 in high-risk patients – Healio
An off-the-shelf, virus-specific T-cell therapy demonstrated proof of concept to enter a clinical trial for the treatment of severe COVID-19 infection, according…
Source/Disclosures
Source: Vasileiou S, et al. Abstract 612. Presented at: ASH Annual Meeting and Exposition (virtual meeting); Dec. 5-8, 2020.
Disclosures:
Vasileiou reports a consultant role with and research funding from AlloVir. Please see the abstract for all other researchers’ relevant financial disclosures.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
An off-the-shelf, virus-specific…
-
General14 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General15 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News23 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General14 hours agoOf saints and sinners | The Spectator Australia